Table of Contents

Neuropharmacology

• You have access

  MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition

  Matthew J. Fell, Christian Mirescu, Kallol Basu, Boonlert Cheewatrakoolpong, Duane E. DeMong, J. Michael Ellis, Lynn A. Hyde, Yinghui Lin, Carrie G. Markgraf, Hong Mei, Michael Miller, Frederique M. Poulet, Jack D. Scott, Michelle D. Smith, Zhizhang Yin, Xiaoping Zhou, Eric M. Parker, Matthew E. Kennedy and John A. Morrow

  Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 397-409; DOI: https://doi.org/10.1124/jpet.115.227587
• You have access

  Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

  Paula L. Vieira-Brock, Lisa M. McFadden, Shannon M. Nielsen, Jonathan D. Ellis, Elliot T. Walters, Kristen A. Stout, J. Michael McIntosh, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein

  Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 463-472; DOI: https://doi.org/10.1124/jpet.114.221945
• 

  You have access

  Inhibition of Plasma Membrane Na/Ca-Exchanger by KB-R7943 or Lithium Reveals Its Role in Ca-Dependent N-methyl-d-aspartate Receptor Inactivation

  Dmitry A. Sibarov, Polina A. Abushik, Ekaterina E. Poguzhelskaya, Konstantin V. Bolshakov and Sergei M. Antonov

  Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 484-495; DOI: https://doi.org/10.1124/jpet.115.227173
• You have access

  Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal

  Ethan M. Anderson, Turi Reeves, Katherine Kapernaros, John K. Neubert and Robert M. Caudle

  Journal of Pharmacology and Experimental Therapeutics December 2015, 355 (3) 496-505; DOI: https://doi.org/10.1124/jpet.115.227629